• 1:中华医学会呼吸病学分会感染学组

摘要(Abstract)：

<正>甲氧西林耐药的金黄色葡萄球菌(methicillin-resistant staphylococcus aureus,MRSA)是引起医院相关性和社区相关性感染的重要致病菌之一[1],自1961年首次发现以来[2],其临床分离率不断增加,2010年我国10省市14所不同地区医院临床分离菌耐药性监测(CHINET)结果显示,临床分离出的4452株金黄色葡萄球菌(以下简称金葡菌)中MRSA比例高达51.7%[3],占革兰阳性球菌的第一位。MRSA已是医院相关性感染最重要的革

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]Liu C,BayerA,Cosgrove SE,et al.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children:executive summary.[J].Clin Infect Dis,2011,52:285-292.
• [2]Matouskova I,Janout V.Current knowledge of methicillin-resistant Staphylococcus aureus and community-associated methicillin-resistant Staphylococcus aureus[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2008,152:191-202.
• [3]朱德妹,汪复,胡付品,等.2010年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2011,11:321-329.
• [4]Gould FK,Brindle R,Chadwick PR,et al.Guidelines(2008)for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus(MRSA)infections in the United Kingdom[J].JAntimicrob Chemother,2009,63:849-861.
• [5]Luna CM,Boyeras Navarro ID.Management of methicillin-resistant Staphylococcus aureus pneumonia[J].Curr Opin Infect Dis,2010,23:178-184.
• [6]American Thoracic Society;Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care Med,2005,171:388-416.
• [7]Torres A,Ewig S,Lode H,et al.Defining,treating and preventing hospital acquired pneumonia:european perspective[J].Inten Care Med,2009,35:9-29.
• [8]Maree CL,Daum RS,Boyle-Vavra S,et al.Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections[J].Emerg Infect Dis,2007,13:236-242.
• [9]Klevens RM,Morrison MA,Nadle J,et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States[J].JAMA,2007,298:1763-1771.
• [10]胡必杰,魏丽,张秀珍,等.医院获得性肺炎发病时间对病原构成影响的回顾性队列研究[J].中华结核和呼吸杂志,2005,28:112-116.
• [11]Masterton RG,Galloway A,French G,et al.Guidelines for the management of hospital-acquired pneumonia in the UK:report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy[J].J Antimicrob Chemother,2008,62:5-34.
• [12]Sanford JP.热病:桑福德抗微生物治疗指南[M].新译第40版.范洪伟,吕玮,吴东,等译.北京:中国协和医科大学出版社,2010.
• [13]Ramirez P,Fernández-Barat L,Torres A.New therapy options for MRSA with respiratory infection/pneumonia[J].Curr Opin Infect Dis,2012,25:159-165.
• [14]Wunderink RG,Mendelson MH,Somero MS,et al.Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus[J].Chest,2008,134:1200-1207.
• [15]Wunderink RG,Niederman MS,Kollef MH,et al.Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia:a randomized,controlled study[J].Clin Infect Dis,2012,54:621-629.